These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1245859)

  • 1. Effect of dopamine-beta-hydroxylase inhibition on cerebral vasospasm in the cat.
    Battista AF; Flamm ES; Goldstein M; Freedman LS
    J Neurosurg; 1976 Feb; 44(2):168-72. PubMed ID: 1245859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral arterial spasm. II. Etiology and treatment of experimental cerebral vasospasm.
    Morooka H
    Acta Med Okayama; 1978 Apr; 32(1):39-49. PubMed ID: 207156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral aterial spasm. I. Adrenergic mechanism in experimental cerebral vasospasm.
    Morooka H
    Acta Med Okayama; 1978 Apr; 32(1):23-37. PubMed ID: 148833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of cerebrovascular CO2 reactivity by inhibition of dopamine beta-hydroxylase.
    Oishi M; Gotoh F; Toyoda M; Seki T; Takeoka T; Takagi S; Niimi T
    Stroke; 1979; 10(4):407-11. PubMed ID: 41344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of inhibitors of dopamine-beta-hydroxylase with uptake of monoamines by chromaffin granular membranes.
    Schlichter D; Da Prada M; Pletscher A
    Eur J Pharmacol; 1975 Nov; 34(1):223-7. PubMed ID: 187432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of noradrenergic system in cerebral arterial spasm after subarachnoid hemorrhage.
    Gotoh F; Muramatsu F; Kanda T; Fukuuchi Y; Yamamoto M; Iwagaki T; Amano T; Okayasu H; Tanaka K
    Acta Neurol Scand Suppl; 1977; 64():342-3. PubMed ID: 268829
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correspondence between the time course of cerebral vasospasm and the level of cerebral dopamine-beta-hydroxylase in rabbits.
    Kovacic S; Bunc G; Ravnik J
    Auton Neurosci; 2006 Dec; 130(1-2):28-31. PubMed ID: 16777494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sympathetic nervous system activity in alcoholic patients treated with disulfiram.
    Lake CR; Major LF; Ziegler MG; Kopin IJ
    Am J Psychiatry; 1977 Dec; 134(12):1411-4. PubMed ID: 920841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychological effects of dopamine-beta-hydroxylase inhibition in normal subjects.
    Hartmann E; Keller-Teschke M
    Biol Psychiatry; 1979 Jun; 14(3):455-62. PubMed ID: 476231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral vascular effects of a new derivative of 1,4-dihydropyridine (YC-93), with special reference to its effect on the experimental basilar artery spasm in cats (author's transl)].
    Handa J
    Nihon Geka Hokan; 1975 Jul; 44(4):343-51. PubMed ID: 1238067
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vivo tritium release assay of human dopamine beta-hydroxylase.
    Hoeldtke RD; Stetson PL
    J Clin Endocrinol Metab; 1980 Oct; 51(4):810-15. PubMed ID: 7419667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of dopamine-beta-hydroxylase in the regulation of norepinephrine biosynthesis in rat brain.
    Wise CD; Belluzzi JD; Stein L
    Pharmacol Biochem Behav; 1977 Dec; 7(6):549-53. PubMed ID: 201940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
    Ishii Y; Fujii Y; Mimura Ch; Umezawa H
    Arzneimittelforschung; 1975 Jan; 25(1):55-9. PubMed ID: 1173769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental cerebral vasospasm in cats: modification by a new synthetic vasodilator YC-93.
    Handa Y; Yoneda S; Koyama T; Matsuda M; Handa H
    Surg Neurol; 1975 Apr; 3(4):195-9. PubMed ID: 1145417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of phenoxybenzamine on the experimental cerebral vasospasm in cats (author's transl)].
    Handa J; Koyama T; Yoneda S; Matsuda M; Handa H
    No Shinkei Geka; 1975 Jul; 3(7):577-84. PubMed ID: 1237809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological effects of dopamine beta-hydroxylase inhibition: a failure to replicate.
    Hartmann E; Oldfield M; Adelman S; Edelberg R
    Psychopharmacology (Berl); 1983; 79(4):352-6. PubMed ID: 6407052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of prostacyclin on cerebral vasospasm--an experimental study].
    Quintana L; Konda R; Ishibashi Y; Okada H; Suzuki J
    No Shinkei Geka; 1982 Oct; 10(10):1049-52. PubMed ID: 6757779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.